This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignees: The Translational Genomics Research Institute, The University of Arizona. Active years: 2017-2020.
Company Filing History:
2 out of 124 
1 out of 1,053 Years Active: 2017-2020
Title: The Innovative Contributions of Travis Dunckley
Introduction
Travis Dunckley is a notable inventor based in Phoenix, AZ, who has made significant contributions to the field of medicinal chemistry. With a focus on developing therapeutic solutions for various diseases, he holds 2 patents that showcase his innovative approach to addressing complex health issues.
Latest Patents
Dunckley's latest patents include "Small molecule inhibitors of DYRK1A and uses thereof." This invention introduces a new class of small molecules with a benzimidazole or imidazopyridine structure that act as inhibitors of the DYRK1A protein. These compounds have potential therapeutic applications for treating Alzheimer's disease, Down syndrome, glioblastoma, autoimmune diseases, and inflammatory disorders, such as airway inflammation. Another significant patent is "Compounds for cognitive enhancement and methods of use thereof." This invention provides compounds that inhibit ROCK activity, which can enhance cognitive function. The patent also covers pharmaceutical compositions that include ROCK inhibitors and methods aimed at improving cognitive function and addressing cognitive decline.
Career Highlights
Throughout his career, Dunckley has worked with esteemed organizations, including the Translational Genomics Research Institute and the University of Arizona. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Dunckley's notable coworkers include Tong Wang and Matthew Huentelman. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Travis Dunckley's contributions to medicinal chemistry through his patents and collaborations highlight his commitment to improving health outcomes. His innovative work continues to pave the way for new treatments and therapies that can significantly impact patients' lives.